Ariel Lopez-Chavez, MD, medical oncologist, director of precision medicine and developmental therapeutics at Allegheny Health Network Cancer Institute, discusses comprehensive genomic profiling and ...

Thousands set to be offered Ozempic to beat cancer - as research shows jabs can reduce risk of deadly disease A fit and ...

Q1 2025 Earnings Call Transcript May 2, 2025 Operator: Thank you for standing by. Hello and welcome to the Summit Therapeutics Q1 2025 Earnings Conference Call. I would now like to turn the call over ...

Data collection continued until the patient’s death or the end of the follow-up period ... to the 8th Edition of the American Joint Committee on Cancer (AJCC) TNM Classification for Lung Cancer (18).

Singer Small Doctor has expressed concern over the decline of Fuji music, a popular Yoruba genre. He believes the genre is “dying” due to a lack of new, rising stars. Small Doctor, on X ...

Fuji singer, Sulaimon Alao Adekunle, popularly known as KS1 Malaika, has replied street-hop artiste Small Doctor, stating that Fuji music is not dying and remains better than his genre.

The latest episode of 'The Last of Us' season 2, released on April 28 in India, explores the aftermath of Joel's shocking death. Ellie and the Jackson community grapple with the loss, as seen in ...

High temperatures, humidity and an approaching cold front are expected to brew up some of the most severe thunderstorms seen in the province so far this year on Tuesday afternoon, according to ...

From bustling Saturday mornings under the pavilion at Norris Park to the quiet corners of a used bookstore tucked into downtown, small businesses across Green Country are navigating a rapidly ...

Early-stage lung cancer usually refers to stages 1, 2, and 3A non-small cell lung cancer (NSCLC) as well as limited-stage small cell lung cancer (SCLC). You may have no symptoms in these early stages ...

In announcing (Chinese) ivonescimab’s Chinese approval in first-line PD-L1-positive non-small cell lung cancer on Friday, Akeso noted that the bispecific drug slashed the risk of death by 22.3% ...